2015
Kirman CR, Proctor DM, Suh M , Hays S. Reduction of hexavalent chromium by gastric fluids from fed and fasted individuals with applications to toxicokinetic modeling. Presented at Society of Toxicology 54th Annual Meeting, San Diego, CA, March 2015.
View Abstract
Topics: chromium , modeling , toxicokinetics
Proctor D, Suh M , Thompson C, Hixon, G. Inhalation cancer risk assessment of titanium dioxide. Presented at Society of Toxicology 54th Annual Meeting, San Diego, CA, March 2015.
View Abstract
Topics: Cancer , risk assessment , titanium dioxide
Harris MA, Thompson CM, Proctor DM, Suh M , Wolf JC, Seiter JM, Chappell MA, Haws LC. Analysis of duodenal crypt health following exposure to Cr(VI) in drinking water. Presented at Society of Toxicology 54th Annual Meeting, San Diego, CA, March 2015.
View Abstract
Topics: chromium , water
Thompson CM, Young RR, Suh M , Dinesdurage H, Elbekai R, Harris MA, Rohr AC, Proctor DM. Hexavalent chromium does not induce mutations in the oral mucosa of transgenic Big Blue® rats following drinking water exposures at a carcinogenic dose. Presented at Society of Toxicology 54th Annual Meeting, San Diego, CA, March 2015.
View Abstract
Topics: carcinogens , chromium , water
2014
Wu C, Fortier KJ, LaPensee K, Fan W, Mitchell M, Cyr PL , Jensen IS . A US hospital economic impact model for oritavancin in ABSSSI patients with risk of MRSA infections. Abstract PSS10 , ISPOR 17th Annual European Congress 2014.
View Abstract
Topics: Health Economics and Outcomes Research (HEOR)
Erichsen R, Kelsh MA , Oliner KS, Nielsen KB, Frøslev T, Lænkholm AV, et al. Prognostic impact of tumor MET expression among patients with stage IV gastric cancer: A Danish cohort study. Presented at International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE), Taipei, Taiwan, October 28–30, 2014.
Topics: Cancer
Jensen IS , Bay C, Cyr PL . Estimating the impact of combining cangrelor and bivalirudin to a U.S. hospital performing PCI procedures. ISPOR 18th Annual International Meeting, New Montreal Quebec, 2014.
Topics: Health Economics and Outcomes Research (HEOR)
Jensen IS , Wu C, Bay CB, Cyr PL . Estimating the clinical value of cangrelor in patients undergoing PCI. International Academy of Cardiology, 19th World Congress on Heart Disease, Boston, MA, 2014.
Topics: Health Economics and Outcomes Research (HEOR)
Wu C, Fortier K, Fan WJ, LePensse K, Bay CB, Cyr PL , Jensen IS . A U.S. hospital budget impact model for oritivancin in ABSSSI patients with risk of MRSA infections. ISPOR 16th Annual European Congress, Amsterdam, Netherlands, 2014.
Topics: Health Economics and Outcomes Research (HEOR)
Bay C, Cyr PL , Jensen IS . Estimating the value of cangrelor from eliminating preloading in coronary artery bypass graft (CABG) patients. ISPOR 16th Annual European Congress, Amsterdam, Netherlands, 2014.
A Division of